- Built on a deep understanding of metabolic networks to identify microorganisms, parameters, and precursors to test. - Move from trial and error to smarter experimental design and faster optimisation. - MINE integrates multi-omics data to see what is happening in microbial ecosystems, interpret the biology, design optimisation cycles, and guide scale-up. - With a decade of microbial biotechnology expertise, Abolis has built a platform that accelerates innovation through data.
| Website | https://www.abolis.fr/mine |
| Revenue | $11.6 million |
| Employees | 9 (7 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Gut Microbiome, Microbiome Testing, Probiotics, Microbiome Analysis, Gut Health, Natural Products, Healthy Products, Microbiome Research, Personalized Nutrition, Microbiome Supplements, Prebiotics, Metagenomics, Microbial Diversity, Microbiome Therapeutics, Functional Foods, Gut Microbiota, Microbial Communities, Microbiome Science, Digestive Health |
Looking for a particular Microbiome Studio employee's phone or email?
The Microbiome Studio annual revenue was $11.6 million in 2026.
7 people are employed at Microbiome Studio.